login
login

Europe Daily Bulletin No. 9030

20 September 2005
Contents Publication in full By article 51 / 53
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The German BAYER company is planning to sell its medical diagnosis subsidiary DIAGNOSTIKA (turnover of EUR 1.3 bn in 2004) to strengthen is medicines position with the acquisition of BHI - BOOTS HEALTHCARE INTERNATIONAL (“Nurofen” and “Strepsils” for EUR 2 bn.

 

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
WEEKLY SUPPLEMENT